We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$187M
Cap. Flow %
-3.95%
Top 10 Hldgs %
49.48%
Holding
1,228
New
25
Increased
10
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
+$5.9M
2
SPLK
Splunk Inc
SPLK
+$2.26M
3
COUP
Coupa Software Incorporated
COUP
+$2.15M
4
BKNG icon
Booking.com
BKNG
+$1.8M
5
PPLI
People Inc
PPLI
+$1.64M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.1M
2
Z icon
Zillow
Z
+$3.18M
3
AGN
Allergan plc
AGN
+$2.69M
4
RNG icon
RingCentral
RNG
+$2.07M
5
REXR icon
Rexford Industrial Realty
REXR
+$2.04M

Sector Composition

Rank Sector Weight
1 Real Estate 58.33%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYRS
1151
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
27
– –
GTHX
1152
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
212
– –
BCEL
1153
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2K ﹤0.01%
124
– –
ORTX
1154
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2K ﹤0.01%
31
– –
AMRS
1155
DELISTED
Amyris Inc.
AMRS
$2K ﹤0.01%
645
– –
RUBY
1156
DELISTED
Rubius Therapeutics, Inc
RUBY
$2K ﹤0.01%
450
– –
FLXN
1157
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2K ﹤0.01%
215
– –
PRVL
1158
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$2K ﹤0.01%
192
– –
PGNX
1159
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
533
– –
PDLI
1160
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
644
– –
BDSI
1161
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2K ﹤0.01%
507
– –
ADMA icon
1162
ADMA Biologics
ADMA
$2.02B
$1K ﹤0.01%
335
– –
AUTL
1163
Autolus Therapeutics
AUTL
$386M
$1K ﹤0.01%
168
– –
CLLS
1164
Cellectis
CLLS
$285M
$1K ﹤0.01%
100
– –
DBC icon
1165
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
$1K ﹤0.01%
100
– –
DNTH icon
1166
Dianthus Therapeutics
DNTH
$5.65B
$1K ﹤0.01%
14
– –
EOLS icon
1167
Evolus
EOLS
$406M
$1K ﹤0.01%
173
– –
EYPT icon
1168
EyePoint Inc
EYPT
$1B
$1K ﹤0.01%
62
– –
GERN icon
1169
Geron
GERN
$943M
$1K ﹤0.01%
880
– –
CBIO
1170
Crescent Biopharma
CBIO
$612M
$1K ﹤0.01%
3
– –
LXRX icon
1171
Lexicon Pharmaceuticals
LXRX
$1B
$1K ﹤0.01%
583
– –
MNKD icon
1172
MannKind Corp
MNKD
$1.21B
$1K ﹤0.01%
1,042
– –
OPTN
1173
DELISTED
OptiNose
OPTN
$1K ﹤0.01%
18
– –
PSNL icon
1174
Personalis
PSNL
$1.27B
$1K ﹤0.01%
176
– –
PTGX icon
1175
Protagonist Therapeutics
PTGX
$8.74B
$1K ﹤0.01%
154
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2020 Portfolio in Review

As of Q2 2020, Daiwa Securities Group held 1,228 positions worth $4.74B, down 51% from $9.64B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Daiwa Securities Group withdrew a net $187M in Q2 2020, closing 23 positions and reducing 14 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Daiwa Securities Group opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $6.27M.

  • Daiwa Securities Group's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 5,000 shares worth $6.27M.
  • Daiwa Securities Group added most to Splunk Inc in Q2 2020, an estimated $2.26M increase.
  • Daiwa Securities Group's biggest Q2 2020 reduction was Zillow, cutting an estimated $3.18M.
  • Daiwa Securities Group fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $11.1M.
  • Daiwa Securities Group's ten largest holdings make up 49% of its $4.74B portfolio in Q2 2020.
  • Daiwa Securities Group opened 25 new positions and closed 23 in Q2 2020.
  • Daiwa Securities Group's portfolio value fell 51% quarter-over-quarter to $4.74B.

Based on Daiwa Securities Group's 13F filing for Q2 2020, filed 11 Aug 2020.